Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure. [electronic resource]
Producer: 20161230Description: 237-44 p. digitalISSN:- 1348-4214
- Angiotensin II Type 1 Receptor Blockers -- pharmacology
- Animals
- Biphenyl Compounds -- pharmacology
- Heart -- drug effects
- Irbesartan
- Male
- Myocardial Infarction -- complications
- Myocardium -- metabolism
- NADPH Oxidase 4
- NADPH Oxidases -- metabolism
- NF-kappa B -- metabolism
- Phosphorylation -- drug effects
- Proto-Oncogene Proteins c-jun -- metabolism
- Rats
- Rats, Sprague-Dawley
- Renal Insufficiency -- complications
- Renin-Angiotensin System -- drug effects
- Tetrazoles -- pharmacology
- Ventricular Dysfunction, Left -- complications
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.